Nadav Kidron, President and CEO, 10% Owner at ORAMED PHARMACEUTICALS INC. (ORMP), bought 1,000 shares at $7.10 ($7K) on 2016-05-12, disclosed to the SEC on 2016-05-12.
Open-market purchase of $7k ORMP by President and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.90 | 300 | $2K | 29.8% |
| 2 | $6.91 | 300 | $2K | 29.8% |
| 3 | $7.00 | 300 | $2K | 30.2% |
| 4 | $7.10 | 100 | $710 | 10.2% |
| Total | $6.95 avg | 1,000 | $7K | 100% |
| Filing → |
| ORMP | SELL | 2021-08-11 | $4.4M | — | Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |